240 related articles for article (PubMed ID: 11802811)
1. Functional mimicry of an anti-idiotypic antibody to nominal antigen on cellular response.
Ma J; Zhou L; Wang D
Jpn J Cancer Res; 2002 Jan; 93(1):78-84. PubMed ID: 11802811
[TBL] [Abstract][Full Text] [Related]
2. Construction and expression of a single chain antibody mimicing human ovarian cancer antigen CA125.
Li AD; Li Z; Wang YH; Zhang YM; Ma J
Cell Mol Immunol; 2006 Feb; 3(1):59-62. PubMed ID: 16549051
[TBL] [Abstract][Full Text] [Related]
3. Induction of anti-idiotypic humoral and cellular immune responses by a murine monoclonal antibody recognizing the ovarian carcinoma antigen CA125 encapsulated in biodegradable microspheres.
Ma J; Samuel J; Kwon GS; Noujaim AA; Madiyalakan R
Cancer Immunol Immunother; 1998 Sep; 47(1):13-20. PubMed ID: 9755874
[TBL] [Abstract][Full Text] [Related]
4. Immunological responses to the tumor-associated antigen CA125 in patients with advanced ovarian cancer induced by the murine monoclonal anti-idiotype vaccine ACA125.
Wagner U; Schlebusch H; Köhler S; Schmolling J; Grünn U; Krebs D
Hybridoma; 1997 Feb; 16(1):33-40. PubMed ID: 9085126
[TBL] [Abstract][Full Text] [Related]
5. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
[TBL] [Abstract][Full Text] [Related]
6. Induction of CA125-specific B and T cell responses in patients injected with MAb-B43.13--evidence for antibody-mediated antigen-processing and presentation of CA125 in vivo.
Noujaim AA; Schultes BC; Baum RP; Madiyalakan R
Cancer Biother Radiopharm; 2001 Jun; 16(3):187-203. PubMed ID: 11471484
[TBL] [Abstract][Full Text] [Related]
7. A monoclonal antiidiotypic antibody ACA 125 mimicking the tumor-associated antigen CA 125 for immunotherapy of ovarian cancer.
Schlebusch H; Wagner U; Grünn U; Schultes B
Hybridoma; 1995 Apr; 14(2):167-74. PubMed ID: 7590775
[TBL] [Abstract][Full Text] [Related]
8. Anti-idiotype induction therapy: anti-CA125 antibodies (Ab3) mediated tumor killing in patients treated with Ovarex mAb B43.13 (Ab1).
Schultes BC; Baum RP; Niesen A; Noujaim AA; Madiyalakan R
Cancer Immunol Immunother; 1998 Jun; 46(4):201-12. PubMed ID: 9671143
[TBL] [Abstract][Full Text] [Related]
9. Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72.
Irvine K; Schlom J
Cancer Immunol Immunother; 1993 May; 36(5):281-92. PubMed ID: 7682893
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the anti-idiotypic responses generated by antibodies to a protein and a hapten: a common interspecies idiotype on antibodies against human albumin induces an idiotypic network in rabbits.
Comacchio RM; Bradley J; Hohmann AW
Immunol Cell Biol; 1996 Feb; 74(1):72-80. PubMed ID: 8934657
[TBL] [Abstract][Full Text] [Related]
11. Murine monoclonal anti-idiotypic antibody as a surrogate antigen for human Her-2/neu.
Baral R; Sherrat A; Das R; Foon KA; Bhattacharya-Chatterjee M
Int J Cancer; 2001 Apr; 92(1):88-95. PubMed ID: 11279611
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of immunological responses in patients with ovarian cancer treated with the anti-idiotype vaccine ACA125 by determination of intracellular cytokines--a preliminary report.
Reinartz S; Boerner H; Koehler S; Von Ruecker A; Schlebusch H; Wagner U
Hybridoma; 1999 Feb; 18(1):41-5. PubMed ID: 10211787
[TBL] [Abstract][Full Text] [Related]
13. Anti-idiotype vaccine against Hodgkin's lymphoma: induction of B- and T-cell immunity across species barriers against CD30 antigen by murine monoclonal internal image antibodies.
Pohl C; Renner C; Schwonzen M; Sieber M; Lorenz P; Pfreundschuh M; Diehl V
Int J Cancer; 1992 Apr; 50(6):958-67. PubMed ID: 1313400
[TBL] [Abstract][Full Text] [Related]
14. Antiidiotype induction therapy: evidence for the induction of immune response through the idiotype network in patients with ovarian cancer after administration of anti-CA125 murine monoclonal antibody B43.13.
Madiyalakan R; Sykes TR; Dharampaul S; Sykes CJ; Baum RP; Hör G; Noujaim AA
Hybridoma; 1995 Apr; 14(2):199-203. PubMed ID: 7590780
[TBL] [Abstract][Full Text] [Related]
15. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
Maruyama H; Zaloudik J; Li W; Sperlagh M; Koido T; Somasundaram R; Scheck S; Prewett M; Herlyn D
Cancer Immunol Immunother; 2000 Jun; 49(3):123-32. PubMed ID: 10881691
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer.
Reinartz S; Hombach A; Köhler S; Schlebusch H; Wallwiener D; Abken H; Wagner U
Cancer Res; 2003 Jun; 63(12):3234-40. PubMed ID: 12810653
[TBL] [Abstract][Full Text] [Related]
17. Network of idiotypic and anti-idiotypic antibodies related to the ovarian carcinoma-associated folate binding protein.
Pupa SM; Bazzini P; Menard S; Colnaghi MI
Anticancer Res; 1992; 12(5):1565-70. PubMed ID: 1332580
[TBL] [Abstract][Full Text] [Related]
18. Idiotypic cascades after injection of the monoclonal antibody OC125. A study in a mouse model.
Schultes BC; Reinsberg J; Wagner U; Schlebusch H; Richter H; Krebs D; Biersack HJ
Cell Biophys; 1994; 24-25():259-66. PubMed ID: 7736531
[TBL] [Abstract][Full Text] [Related]
19. Induction of specific immunity to human colon carcinoma by anti-idiotypic antibodies to monoclonal antibody CO17-1A.
Herlyn D; Ross AH; Iliopoulos D; Koprowski H
Eur J Immunol; 1987 Nov; 17(11):1649-52. PubMed ID: 3500066
[TBL] [Abstract][Full Text] [Related]
20. Immunological properties of a single-chain fragment of the anti-idiotypic antibody ACA125.
Reinartz S; Wagner U; Giffels P; Gruenn U; Schlebusch H; Wallwiener D
Cancer Immunol Immunother; 2000 Jul; 49(4-5):186-92. PubMed ID: 10941901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
